205 related articles for article (PubMed ID: 17966101)
1. [Postoperative radiotherapy for non-small cell lung cancer: evidence based data and clinical practice].
Kepka L; Bujko K
Pneumonol Alergol Pol; 2007; 75(3):256-61. PubMed ID: 17966101
[TBL] [Abstract][Full Text] [Related]
2. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA;
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766
[TBL] [Abstract][Full Text] [Related]
3. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
[TBL] [Abstract][Full Text] [Related]
4. ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer.
Decker RH; Langer CJ; Rosenzweig KE; Chang JY; Gewanter RM; Ginsburg ME; Kong FM; Lally BE; Videtic GM; Movsas B
Am J Clin Oncol; 2011 Oct; 34(5):537-44. PubMed ID: 21946673
[TBL] [Abstract][Full Text] [Related]
5. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
Barlési F
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
[TBL] [Abstract][Full Text] [Related]
6. Early-stage NSCLC: the role of radiotherapy and systemic therapy.
Bunn PA
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244
[TBL] [Abstract][Full Text] [Related]
7. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
Baumann M
Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
[No Abstract] [Full Text] [Related]
8. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
9. Localized non-small cell lung cancer: adjuvant radiotherapy in the era of effective systemic therapy.
Bogart JA; Aronowitz JN
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5004s-5010s. PubMed ID: 16000604
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
Tanaka F; Wada H
Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
[TBL] [Abstract][Full Text] [Related]
11. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
12. [Effect of postoperative thoracic radiotherapy on the survival of patients with stage IIIA (N2 disease) non-small-cell lung cancer].
Chabowski M; Orłowski TM
Pol Merkur Lekarski; 2004 Oct; 17(100):345-8. PubMed ID: 15690698
[TBL] [Abstract][Full Text] [Related]
13. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE; Rabin MS
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant treatment of early stage non-small-cell lung cancer.
Wada H
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):102-5. PubMed ID: 10442375
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant treatment in resected non-small cell lung cancer: current and future issues.
Remon J; Lianes P; Martínez S; Velasco M; Querol R; Zanui M
Crit Rev Oncol Hematol; 2013 Nov; 88(2):375-86. PubMed ID: 23809199
[TBL] [Abstract][Full Text] [Related]
16. [Multimodal therapy of small cell and non-small cell lung carcinoma].
Serke M; Kollmeier J
Dtsch Med Wochenschr; 2007 Jun; 132(22):1221-4. PubMed ID: 17520508
[TBL] [Abstract][Full Text] [Related]
17. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.
Wakelee HA; Stephenson P; Keller SM; Wagner H; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
Lung Cancer; 2005 Jun; 48(3):389-97. PubMed ID: 15893008
[TBL] [Abstract][Full Text] [Related]
18. Should aggressive surgery ever be part of the management of small cell lung cancer?
Waddell TK; Shepherd FA
Thorac Surg Clin; 2004 May; 14(2):271-81. PubMed ID: 15382303
[TBL] [Abstract][Full Text] [Related]
19. [Early-stage NSCLC. The renaissance of radiotherapy in early-stage non-small cell lung cancer].
Girard N; Mornex F
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S79-87. PubMed ID: 18971830
[TBL] [Abstract][Full Text] [Related]
20. [Commentary for the work L. Kepka et al.: Postoperative radiotherapy for non-small cell lung cancer: evidence based data and clinical practice].
Jodkiewicz ZM
Pneumonol Alergol Pol; 2007; 75(3):211-2. PubMed ID: 17966094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
